Citations

Showing 10 of 108104 citations.

Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma
Wongjarupong, Nicha , Yang, Lu , Johnson, Stephen , Yao, Janet , Harrington, Sean C., Nordyke, Cynthia K., Eaton, John E. , Gossard, Andrea A., Oli, Sharad , Ali, Hamdi A. , Lavu, Sravanthi , Giama, Nasra H., Hassan, Fatima, Ali, Hawa M. , Gores, Gregory J. , Topazian, Mark , Kashyap, Purna , Roberts, Lewis R. , Gores, Gregory J. , Yao, Janet Z, Hassan, Fatima A, Enders, Felicity T, Roberts, Lewis R , Miyabe, Katsuyuki , Chandrasekhara, Vinay , Chen, Jun , Chia, Nicholas , Walther-António, Marina , Enders, Felicity , Ilyas, Sumera I.

Mayo Clinic

Cancers | April 24, 2022 | Volume: 14 | Issue: 9 | Pages: 2120

10.3390/cancers14092120 | PMID 35565248 Get It

Background: Primary sclerosing cholangitis (PSC) is a major risk factor for cholangiocarcinoma (CCA). We investigated biliary and fecal microbiota to determine whether specific microbes in the bile or stool are associated with PSC or CCA. Methods: Bile was obtained from 32 patients with PSC, 23 with CCA with PSC, 26 with CCA without PSC, and 17 controls. Over 90% of bile samples were from patients with perihilar CCA. Stool was obtained from 31 patients with PSC (11 were matched to bile), 16 with CCA with PSC (10 matched to bile), and 11 with CCA without PSC (6 matched to bile). Microbiota composition was assessed using 16SrRNA-marker-based sequencing and was compared between groups. Results: Bile has a unique microbiota distinguished from negative DNA controls and stool. Increased species richness and abundance of Fusobacteria correlated with duration of PSC and characterized the biliary microbiota in CCA. Stool microbiota composition showed no significant differences between groups. Conclusions: We identified a unique microbial signature in the bile of patients with increased duration of PSC or with CCA, suggesting a role for microbiota-driven inflammation in the pathogenesis and or progression to perihilar CCA. Further studies are needed to test this hypothesis.
Unloading the right to fill the left: vasodilation to treat hypotension: a case report
Ezzeddine, Fatima M. , Bois, Melanie C. , Borlaug, Barry A. , Borlaug, Barry A , Ezzeddine, Fatima

Mayo Clinic

European Heart Journal - Case Reports | April 23, 2022 | Volume: 6 | Issue: 6 | Pages: No page available

10.1093/ehjcr/ytac179 | PMID 35668846 Get It

Abstract Background Management of pulmonary hypertension (PH) in the setting of heart failure with preserved ejection fraction (HFpEF) can be challenging. Herein, we describe the case of a patient with HFpEF and combined pre- and post-capillary PH who showed striking improvement with sildenafil. Case summary A 74-year-old man presented with exertional dyspnea and near-syncope. He underwent a hemodynamic exercise study that showed evidence of HFpEF with pre- and post-capillary PH. Right ventricular endomyocardial biopsy showed interstitial fibrosis and mild hypertrophy, with no evidence of infiltrative or storage diseases. The patient was treated with sildenafil 20 mg three times daily, which resulted in significant symptomatic and functional improvement in 12 years of follow-up. Discussion Phosphodiesterase 5 inhibitors are currently not approved by the United States Food and Drug Administration for treatment of PH in heart failure and are used off-label in patients with heart failure. This case illustrates the importance of unloading the right ventricle to improve cardiac output in patients with diastolic dysfunction and combined pre- and post-capillary PH. Although promising, future studies are needed to validate these findings.
Gastrointestinal symptoms as a predictor of deep endometriosis of the pelvic posterior compartment on magnetic resonance imaging
Fadadu, Priyal , Cope, Adela G. , Weng, Chia‐Sui , Mara, Kristin C. , Khan, Zaraq , VanBuren, Wendaline M. , Fadadu, Priyal P , Mara, Kristin C , Burnett, Tatnai L.

Mayo Clinic

Journal of Endometriosis and Pelvic Pain Disorders | April 23, 2022 | Volume: 14 | Issue: 2 | Pages: 92-97

10.1177/22840265221093262 Get It

Objective: To determine if gastrointestinal (GI) symptoms can predict deep endometriosis (DE) of the posterior pelvic compartment on magnetic resonance imaging (MRI). Methods: Patients with suspected endometriosis undergoing endometriosis protocol MRI at an academic center between 9/1/2015 and 7/31/2018 were identified. Presenting GI symptoms were collected via a standardized survey instrument prospectively at initial presentation. MRI and interdisciplinary conference notes were reviewed to identify posterior compartment DE (rectosigmoid, uterosacral ligaments, posterior cul de sac, and pelvic side walls). Associations between symptoms and DE were evaluated. Results: A total of 104 patients met inclusion criteria, and 89 (85.6%) presented with at least one GI symptom. Posterior compartment DE was identified on MRI in 47 patients (45.2%). The GI symptom that most strongly predicted DE was a bowel movement resulting in pain relief (OR 3.36, 95% CI 1.31–8.61, p = 0.012), with sensitivity, specificity, positive and negative predictive values 0.42, 0.82, 0.67, and 0.63, respectively. Other GI symptoms such as nausea, vomiting, rectal bleeding, change in frequency of bowel movements, and pain exacerbation by bowel movements did not significantly correlate to having DE. Of the 15 patients with no GI symptoms, 5 were found to have posterior compartment DE. Conclusion: In patients with suspected endometriosis, those who noted that bowel movements relieved their pain had more than three times the odds of having DE of the posterior compartment on MRI. Preoperative evaluation with MRI may be of value in these patients; however, lack of gastrointestinal symptoms does not exclude the possibility of posterior compartment DE.
Comparing Post-Operative Outcomes of Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: Neoadjuvant Therapy Versus Surgery First Approach
Hyman, David W., Almerey, Tariq , Mujkanović, Amer , Hammons, Isaac, Tice, Mary, Stauffer, John

Mayo Clinic

The American Surgeon™ | April 23, 2022 | Volume: 88 | Issue: 8 | Pages: 1868-1874

10.1177/00031348221087900 | PMID 35465681 Get It

Objectives Optimal use of surgery first (SF) vs neoadjuvant therapy (NAT) for localized pancreatic ductal adenocarcinoma (PDAC) is still unclear. There is concern that NAT may result in worsened post-operative outcomes. Our study objectives were to show the impact of NAT on post-operative morbidity and mortality. Methods All patients undergoing resection for PDAC between 1/1/2010 and 12/31/2020 were reviewed and those who underwent pancreaticoduodenectomy (PD) were included. Demographics, perioperative details, and pathology details were gathered. Data pertaining to 90-day complications were obtained and graded according to international consensus guidelines. Those undergoing SF were compared to those who had NAT. Categorical variables were compared by Fisher’s exact test and continuous variables by Student’s t-test. Results Two hundred and forty-one subjects who underwent PD for PDAC were included in this review. There was no significant difference in the rate of major morbidity between subjects who received NAT vs SF (19.4 vs 20.3%, P = 1.0). Similarly, there were no significant differences in the rates of mortality (3.1 vs 4.2%, P = .742), post-operative pancreatic fistula (8.2 vs 10.5%, P = .658), or post-pancreatectomy hemorrhage (7.1 vs 7.7%, P = 1.0), respectively. Conclusion Post-operative outcomes are not worsened by the use of the NAT approach prior to PD for PDAC. Further investigation is needed to reveal which patient subgroups may benefit from the use of NAT, especially regarding survival.
Providing Asthma Management in the Retail Clinic Setting
Prigge, Kimberly , Holtz, Kelly K. , Mara, Kristin C. , Meek, Alicia, Mara, Kristin, Mara, Kristin C

Mayo Clinic

Journal of Primary Care & Community Health | April 23, 2022 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/21501319221092256 | PMID 35465761 Get It

Objective: To determine whether there are differences in asthma management provided in the retail clinic setting versus in the primary care setting, and whether it would increase the number of well controlled asthmatics as determined by ACT score of 20 or greater, and less than or equal to 1 ED or hospital visit due to asthma, within 6 months. Methods: All asthma patients with an asthma control test (ACT) of 19 or less, received a new or updated asthma action plan (AAP) at the visit. If the patient presented to the retail clinic during an asthma exacerbation or with any asthma symptoms, they were not given an ACT and received usual care. Asthma quality data was retrospectively collected for primary care patients seen in the 6-months prior to as well as up to 6 months after the patient’s enrollment visit. Results: There was no significant difference in the number of admissions between locations in either the pre-implementation period or the post-implementation period for either the pediatric or adult cohort. There was a significant improvement in the percentage of pediatric and adult patients with at least 1 ACT in the post-implementation compared to pre-implementation for both retail clinic and primary care sites. The percentage of pediatric and adult patients with at least 1 AAP increased in the post-implementation compared to pre-implementation for both retail clinic and primary care sites. Conclusion: Retail clinics may be able to provide asthma management with similar outcomes to primary care settings.
The Effects of Cannabinoids on Sleep
Hayes, Lisa , Cox, Chaun, Eatwell, Lindy, Deyo-Svendsen, Mark , Kolla, Bhanu Prakash , Deyo-Svendsen, Mark E , Mansukhani, Meghna P , Mansukhani, Meghna P.

Mayo Clinic

Journal of Primary Care & Community Health | April 23, 2022 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/21501319221081277 | PMID 35459406 Get It

The use of cannabis products to help with sleep and various other medical conditions by the public has increased significantly in recent years. Withdrawal from cannabinoids can lead to sleep disturbance. Here, we describe a patient who developed significant insomnia leading to worsening anxiety, mood, and suicidal ideation in the setting of medical cannabis withdrawal, prompting presentation to the Emergency Department and inpatient admission. There is a limited evidence base for the use of cannabis products for sleep. We provide a comprehensive review evaluating the literature on the use of cannabis products on sleep, including an overview of cannabis and related psychoactive compounds, the current state of the law as it pertains to the prescribing and use of these substances, and potential side effects and drug interactions. We specifically discuss the impact of cannabis products on normal sleep and circadian sleep-wake rhythms, insomnia, excessive daytime sleepiness, sleep apnea, parasomnias, and restless legs syndrome. We also describe the effects of cannabis withdrawal on sleep and how this increases relapse to cannabis use. Most of the studies are observational but the few published randomized controlled trials are reviewed. Our comprehensive review of the effects of cannabis products on normal sleep and sleep disorders, relevant to primary care providers and other clinicians evaluating and treating patients who use these types of products, shows that cannabis products have minimal to no effects on sleep disorders and may have deleterious effects in some individuals. Further research examining the differential impact of the various types of cannabinoids that are currently available on each of these sleep disorders is required.
Overall patient experience with a virtual hybrid hospital at home program
Maniaci, Michael J. , Garcia, John P. , Maita, Karla C. , Forte, Antonio J. , Torres-Guzman, Ricardo A, Garcia, John P , Forte, Antonio Jorge , Paulson, Margaret R. , Maniaci, Michael J , Torres‐Guzman, Ricardo A. , Ávila, Francisco R.

Mayo Clinic

SAGE Open Medicine | April 23, 2022 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/20503121221092589 | PMID 35481244 Get It

Objectives: Traditional hospital at home models often have high patient experience scores. The purpose of this study is to look at the patient experience of a new virtual hybrid model of hospital at home called Advanced Care at Home. Methods: Patients in Mayo Clinic’s Advanced Care at Home program received a survey via email from 1 January–31 May 2021. Each survey consisted of 20 questions divided into 18 multiple-choice and two open-ended questions. Results: Ninety-nine surveys were sent and 41 partially or completely finished surveys were returned for a response rate of 41.4%. Patients responded positively, denoted by answering “strongly agree or somewhat agree,” with regard to the ability to reach the team right away 100% of the time, being kept informed 92% of the time, the command center responding promptly to their needs 95% of the time, the team providing comfort and support 98% of the time, feeling comfortable with interacting with their provider by phone or tablet 95% of the time, the ease of use from the equipment 97% of the time, the virtual and in-person staff working well together 98% of the time, the staff treating patients with courtesy and respect 100% of the time, and the ease of understanding the discharge process and feeling ready to leave the program 100% of the time. All providers received positive responses on listening ⩾88% of the time. Patients gave a top rating in likelihood to recommend the program 100% of the time. Conclusion: Overall, the Advanced Care at Home model of hospital at home was highly recommended by patients. Patients scored the program high on responsiveness, staff engagement and communication, ease of equipment use, and readiness for discharge, strengthening the overall confidence in this novel program.
Hepatology highlights
Watkins, Ryan , Conboy, Caitlin B. , Penrice, Daniel D. , Díaz, Luis Antonio , Arab, Juan Pablo , Ilyas, Sumera I.

Mayo Clinic

Hepatology | April 22, 2022 | Volume: 75 | Issue: 5 | Pages: 1071-1072

10.1002/hep.32488 Get It

Use of intravascular optical coherence tomography to confirm the diagnosis of a carotid web in a patient with recurrent ipsilateral embolic strokes and evaluate the response to stenting
Oushy, Soliman , Flemming, Kelly D. , Cloft, Harry J. , Cloft, Harry, Savastano, Luis E., Oushy, Soliman H , Flemming, Kelly D , Savastano, Luis

Mayo Clinic

Interventional Neuroradiology | April 22, 2022 | Volume: 29 | Issue: 2 | Pages: 217-221

10.1177/15910199221080878 | PMID 35451886 Get It

A Carotid web (CaW) is defined as a focal shelf-like projection of non-atheromatous, fibrous tissue along the posterior wall of the carotid bulb. CaW are rare and commonly overlooked lesions increasingly recognized as a cause of stroke in otherwise healthy patients. Intravascular imaging modalities such as intravascular ultrasound and optical coherence tomography (OCT) have been proposed as an adjunct to digital subtraction angiography for the evaluation of CaW. However, the use of OCT in CaW has yet to be described. This report investigated the utility of OCT as an adjunct imaging modality in the evaluation of CaW morphology in a young patient with recurrent ischemic strokes.